Tanishq: Counterfeit Drug Network Involving  Jha Busted in Delhi

Tanishq: Counterfeit Drug Network Involving Jha Busted in Delhi

Counterfeit Drug Network Involving Tanishq Jha Busted in Delhi

A counterfeit drug network was dismantled in Lajpat Nagar, Delhi, on September 1, 2025, leading to the arrest of several individuals, including Anirudh Rai, who was caught delivering a package containing Tramadol premix.

The police laid a trap to apprehend the courier, which resulted in the discovery of a broader network linking suppliers in Uttarakhand to traders in Delhi and a manufacturer in Bihar. The operation revealed a complex supply chain that involved multiple players.

Among those implicated is Tanishq Jha, whose factory in Patna was reportedly producing counterfeit medicines after its license had expired. This highlights the ongoing issue of illegal pharmaceutical production in the region.

Authorities seized counterfeit medicines and psychotropic drugs valued at nearly Rs 50 crore during the operation. Amit, another individual arrested, was found to have stored 20 kilograms of Tramadol premix in his warehouse in Roorkee.

Prashant acted as an intermediary, connecting suppliers to buyers across North India, facilitating the distribution of these counterfeit drugs. The scale of this operation underscores the significant financial stakes involved, with drugs sold to traders for Rs 50,000 per kilogram.

Senior Crime Branch officers stated, “The goal was to trace the supply chain behind the material,” indicating the investigative focus on understanding the network’s structure. They noted that when factories shut down or excess stock remains, middlemen often attempt to move the material quickly.

One officer close to the investigation explained, “The profits would then be shared between him and the trader who had sourced the material,” illustrating the profit-driven motives behind such illegal activities.

The pharmaceutical belt around Roorkee has many small manufacturers that emerged after Uttarakhand was carved out of Uttar Pradesh, contributing to the prevalence of counterfeit drugs in the area.

Crime Branch officers elaborated on the network’s complexity, stating, “You have suppliers of raw material, brokers who connect buyers and sellers, transporters who move the goods, and finally these manufacturing units where the raw material is converted into tablets or syrups.” This comprehensive view of the operation highlights the challenges law enforcement faces in combating such networks.

As investigations continue, authorities are expected to uncover more details regarding the extent of the network and its operations. Details remain unconfirmed.

  • March 10, 2026